310 related articles for article (PubMed ID: 7909285)
1. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
3. A one-week dose-ranging study of inhaled salmeterol in children with asthma.
Weinstein S; Chervinsky P; Pollard SJ; Bronsky EA; Nathan RA; Prenner B; Howland WC; Stahl E; Liddle R
J Asthma; 1997; 34(1):43-52. PubMed ID: 9033439
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
5. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
[TBL] [Abstract][Full Text] [Related]
6. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
11. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of salmeterol in childhood asthma.
Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
[TBL] [Abstract][Full Text] [Related]
13. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
Grove A; Lipworth BJ
Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
Jones KP
Thorax; 1994 Oct; 49(10):971-5. PubMed ID: 7974313
[TBL] [Abstract][Full Text] [Related]
16. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
[TBL] [Abstract][Full Text] [Related]
19. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
